Ireland has published a landmark draft national drugs strategy, setting out how the country plans to tackle the escalating harms of drug and alcohol misuse through 2026 to 2029. The Department of Health developed the blueprint, marking a decisive shift towards a health-led approach to drug use. It puts treatment, harm reduction and recovery ahead of punitive measures.

The figures tell a worrying story. In 2024, services treated 13,300 cases of problem drug use, a 50 per cent jump since 2017. That same year, 8,745 cases of harmful alcohol use came through, the highest annual total in over a decade. Cocaine has now overtaken opioids as the primary drug of concern, making up 40 per cent of all drug treatment cases.

“A society where the harms from drug and alcohol use are minimised for individuals, children, families and communities.” Strategy Vision Statement

Ireland Drug Policy: A Framework Built on Five Pillars

Ireland’s national drugs strategy organises its response around five strategic pillars. The first pillar targets protection, focusing on shielding individuals, children, families and communities from the harmful effects of drug and alcohol use. Schools, youth services and community programmes will lead on preventing young people from starting in the first place.

The second pillar pushes for equal access to high-quality services across all six HSE health regions. This directly addresses the well-documented gaps in treatment availability between urban and rural areas. The third pillar champions recovery as an ongoing journey rather than a destination, weaving recovery-oriented interventions and peer-led networks into treatment settings, including prisons.

The fourth pillar carries the most political weight. The strategy commits to putting health first for people who meet the criminal justice system because of drug use. A new health diversion scheme will route those caught carrying drugs for personal use to health services rather than prosecution. Public health experts and the Citizens’ Assembly on Drug Use have pushed for this change for years.

The fifth pillar tackles preparedness. Ireland’s drug market is growing more complex and more globally connected. Synthetic drugs sit at the sharpest end of that threat. The nitazene opioids, which caused overdose clusters in Dublin in 2023 and 2024, are a stark example of how quickly new substances can cause devastation.

National Drugs Strategy Faces Record Cocaine and Polydrug Demand

Ireland’s data paints a clear picture of the challenge ahead. The country holds the second-highest prevalence of cocaine use among 15-to-34-year-olds across the European Union. In 2024, 60 per cent of drug treatment cases involved polydrug use, meaning patients took two or more substances together. Harmful alcohol use featured in a third of those cases.

The 2022 figures on drug poisoning deaths are sobering. Services recorded 243 deaths that year. Opioids contributed to 65 per cent of them, benzodiazepines to 48 per cent, and cocaine to 34 per cent. The median age at death stood at just 45. Those numbers represent not just statistics but preventable losses that better intervention could reduce.

Crack cocaine is also becoming harder to ignore. Treatment demand for crack rose 11 per cent between 2023 and 2024. Use among people already on opioids is growing, which clinicians warn worsens long-term outcomes. New semi-synthetic cannabinoids are another concern. By 2024, one in three drug users aged 18 and over had used hexahydrocannabinol (HHC) in the past year, a substance only formally controlled in Ireland in July 2025.

National Drugs Strategy Puts Prevention and Young People First

Prevention runs through the national drugs strategy like a spine. Stakeholders were clear that previous plans underinvested in this area. The new strategy commits to school and community-based programmes to delay and prevent young people from starting with alcohol and drugs. It also extends that focus to universities, sporting bodies and nighttime economy venues.

The numbers make the case for early action. Among young people who started drinking at age 14 or younger, 35 per cent used cannabis by age 20 and 50 per cent used other drugs. Among those who held off until 17 or never drank at all, those figures dropped to 10 per cent and 8 per cent respectively. Starting later makes a real difference. The strategy also calls out the mental health risks of high-potency cannabis, a theme that came up repeatedly among doctors and psychiatrists involved in drafting the plan.

Governance Overhaul: Fixing What Went Wrong Before

The strategy is frank about past failings. Fragmented delivery and weak accountability undermined previous plans. The new governance model runs across three tiers to fix that. The Cabinet Committee on Health sits at the top, overseeing the whole national drugs strategy. A dedicated Minister of State for the National Drugs Strategy carries cross-government responsibility, working alongside an Inter-Departmental Committee that brings together Health, Justice, Education, Social Protection and Rural Affairs.

The middle tier introduces a new National Implementation and Monitoring Committee (NIMC). An independent chair, appointed for a four-year term, will lead it. The committee will publish annual progress reports and flag risks early. Below that, the six HSE health regions take charge of planning, funding and delivering services on the ground. Crucially, they will pull all public drug service funding into a single pot, ending the fragmentation that has hampered delivery in the past.

Record Public Spending and the Road Ahead

Government spending on drug-related programmes hit €338 million in 2024, up 40 per cent since 2017. The HSE’s own spend grew 44 per cent in that same period. The strategy accepts that current funding will not be enough and commits to building an evidence-based benchmark for what a gold-standard, integrated service should look like. A Health Technology Assessment will support that work.

The first two-year action plan, covering 2026 to 2027, uses the RE-AIM framework. This tool assesses five dimensions: Reach, Effectiveness, Adoption, Implementation and Maintenance. It gives the strategy an inbuilt evaluation structure from day one. A second action plan for 2028 to 2029 will follow, shaped by what the first phase delivers.

Ireland also takes on a bigger role internationally. When it assumes the EU Council Presidency in 2026, it will chair the horizontal working party on drugs and lead development of the implementation framework for the EU Drugs Strategy.

“Implementation will require a major step-change in how the state responds to drug use.” Citizens’ Assembly on Drug Use

The Progression

The draft national drugs strategy now goes out for consultation before formal publication. This is the most thorough and evidence-grounded response to drug and alcohol harm that Ireland has put forward. It centres lived experience, names the failures of the past, and sets out the structural changes needed to meet the scale of what communities face.

For families and communities that have carried the weight of drug-related harm for decades, ambition on paper is not enough. The real test of this national drugs strategy is whether the government delivers it, and how quickly.

By Policy & Health Correspondent 24 February 2026 | Dublin, Ireland

Source: dbrecoveryresources